The benefit of using natural micronised progesterone pessaries for the treatment of endometrial hyperplasia without atypia
Background. Endometrial hyperplasia without atypia is associated with oestrogen-progesterone imbalance, menstrual disturbances, and abnormal bleeding, while natural micronised progesterone may offer a physiological therapeutic approach, although its clinical, morphological, and hormonal effects require further investigation. The reviewed studies addressed progesterone pharmacology, hyperplasia risk factors, treatment outcomes, and disease progression, but evidence on the clinical, morphological, ultrasound, hormonal, and tolerability effects of natural micronised progesterone in pessary form remained limited. This study purposed to determine the comparative clinical efficacy and safety of natural micronised progesterone in patients with endometrial hyperplasia without atypia. Materials and methods. This prospective controlled clinical observation study was conducted at the National Centre for Maternal and Child Health in Bishkek, Kyrgyzstan. Data were collected based on clinical observations of 50 patients aged 30–50 years with histologically confirmed endometrial hyperplasia without atypia. The patients were divided into two non-randomised groups (main and control) of 25 each according to the prescribed therapy, reflecting routine clinical practice. Results. The study established that natural micronised progesterone was associated with a faster normalisation of clinical symptoms, shorter time to remission and a higher rate of complete clinical recovery. Morphological normalisation of the endometrium was achieved in 84 % of cases, compared to 60 % (p = 0.02). A reduction in endometrial thickness from 14.2 ± 1.3 mm to 5.8 ± 0.7 mm was accompanied by the restoration of its structure and contour definition. Hormonal changes included a reduction in oestrogen to 98 ± 15 pg/ml and an increase in progesterone to 14.8 ± 1.5 ng/ml, normalising their ratio. These changes were less pronounced in the control group. The incidence of adverse reactions was 4 versus 28 % (p < 0.05), the need for treatment adjustment was 0 versus 16 %, and therapy discontinuation was 0 versus 12 %, reflecting the treatment’s better tolerability. Conclusions. Natural micronised progesterone provided a more complete clinical, morphological and hormonal response, with a favourable safety profile.
Authors
- Veronika Tursunova (ORCID: https://orcid.org/0000-0002-3042-2664)
- G. Subanova (ORCID: https://orcid.org/0000-0003-1003-678X)
- G.K. Karimova (ORCID: https://orcid.org/0000-0003-1931-1127)
- N. Karimova (ORCID: https://orcid.org/0000-0002-4018-0873)
- A. Egemkulova (ORCID: https://orcid.org/0009-0009-8796-9562)
Institutions
- Osh State University (KG)
- Bukhara State Medical Institute named after Abu Ali ibn Sino (UZ)
Publication Details
- Journal
- INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
- Published
- 2026-11-14
- DOI
- https://doi.org/10.22141/2224-0721.22.7.2026.1780
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00